A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor.
Fallacara AL, Zamperini C, Podolski-Renić A, Dinić J, Stanković T, Stepanović M, Mancini A, Rango E, Iovenitti G, Molinari A, Bugli F, Sanguinetti M, Torelli R, Martini M, Maccari L, Valoti M, Dreassi E, Botta M, Pešić M, Schenone S.
Fallacara AL, et al. Among authors: stepanovic m.
Cancers (Basel). 2019 Jun 19;11(6):848. doi: 10.3390/cancers11060848.
Cancers (Basel). 2019.
PMID: 31248184
Free PMC article.